Skip to main content
. 2019 Sep 11;9:13083. doi: 10.1038/s41598-019-49581-4

Figure 1.

Figure 1

(A) Representative image of regulatory B cells in control and gastric cancer patients. (B) Percentage of CD19+IL-10+cells among CD19+ B cells in peripheral blood obtained from gastric cancer patients and healthy controls. The frequency of Bregs was significantly higher in gastric cancer patients than in healthy controls (P = 0.0016).